ENTITY
SMARTSCORE: 3/5
Celltrion Inc

Celltrion Inc (068270 KS)

597
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
01 Jun 2025 00:30

APAC Healthcare Weekly (June 1)- Eisai, Daiichi, Samsung Bio, SK Bioscience, CSPC, Hengrui Pharma

​Eisai's Dayvigo approved in China. Daiichi Sankyo withdrew BLA in US. Samsung Bio secures CMO contracts. SK Bioscience expands vaccine...

Logo
457 Views
Share
bullishHD Hyundai
28 May 2025 05:03

Korea Value Up: Outperformance Relative to KOSPI200 & KOSDAQ150 Likely to Attract Greater Capital

Korea Value Up index is up 8.2% from 30 September 2024 to 28 May 2025, outperforming KOSPI 200 (up 3.4%) and KOSDAQ 150 (down 7.9%) in the same...

Logo
272 Views
Share
27 May 2025 23:05

KRX Short Interest Weekly (May 23rd): Celltrion, Hanmi Semi, Meritz Financi

We analyzed KRX short interest report for the past week and highlighted short interest changes in Celltrion (068270 KS), Hanmi Semi (042700 KS),...

Logo
215 Views
Share
25 May 2025 23:15

KRX Foreign Holding Weekly (May 23rd): Hyosung Heavy, SK Hynix, Samsung Electronics

We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Hyosung Heavy, SK Hynix, Samsung Electronics.

Logo
304 Views
Share
25 May 2025 00:30

APAC Healthcare Weekly (May 25)- 3SBio, Samsung Biologics, Celltrion, CSPC Pharma, Chugai

APAC healthcare companies continued to get approvals for new products and initiates clinical trials. The companies continued with acquisitions and...

Logo
581 Views
Share
x